Pharmacodynamics of Human Immunodeficiency Virus Type 1 Protease Inhibitors-Reference-Cited by-同舟云学术

Pharmacodynamics of Human Immunodeficiency Virus Type 1 Protease Inhibitors

Published:2000-06-01 Issue:Supplement_2 Volume:30 Page:S151-S159
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Acosta Edward P.,Kakuda Thomas N.,Brundage Richard C.,Anderson Peter L.,Fletcher Courtney V.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/30/Supplement_2/S151/20903372/30-Supplement_2-S151.pdf

Reference37 articles.

1. Concentration-controlled zidovudine therapy;Fletcher;Clin Pharmacol Ther,1998

2. Intracellular phosphorylation of stavudine and 3TC correlates with their antiviral activity in naive and zidovudine experienced HIV-infected patients;Sommadossi,1998

3. Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection;Peter;Pharm Res,1998

4. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease;Danner;N Engl J Med,1995

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients;Biomedicines;2021-08-09

2. Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns;AIDS;2021-07-01

3. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection;Frontiers in Immunology;2021-03-26

4. Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat;Biomedicines;2021-03-18

5. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice;Current HIV Research;2019-10-23